Acasti Pharma Inc.
NASDAQ:ACST
Overview | Financials
Company Name | Acasti Pharma Inc. |
Symbol | ACST |
Currency | USD |
Price | 3.37 |
Market Cap | 34,171,463 |
Dividend Yield | 0% |
52-week-range | 1.98 - 3.6 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Prashant Kohli |
Website | https://www.acastipharma.com |
An error occurred while fetching data.
About Acasti Pharma Inc.
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD